The University of Pennsylvania has settled with the federal government over the death of an 18-year-old participant in a gene-therapy study in 1999.
The university will pay $517,496 to settle charges that researchers misled regulators during the study that led to the death of Jesse Gelsinger.
The civil settlement by the U.S. Justice Department restricted future clinical research by three scientists involved in the study, including the principal investigator, James M. Wilson. Neither Dr. Wilson nor Penn admitted liability. The settlement notes that Penn has strengthened its management of clinical research.
We're sorry. Something went wrong.
We are unable to fully display the content of this page.
The most likely cause of this is a content blocker on your computer or network.
Please allow access to our site, and then refresh this page. You may then be asked to log in, create an account if you don't already have one, or subscribe.
If you continue to experience issues, please contact us at 202-466-1032 or help@chronicle.com